164 related articles for article (PubMed ID: 38332004)
21. Dual-Centre Harmonised Multimodal Positron Emission Tomography/Computed Tomography Image Radiomic Features and Machine Learning Algorithms for Non-small Cell Lung Cancer Histopathological Subtype Phenotype Decoding.
Khodabakhshi Z; Amini M; Hajianfar G; Oveisi M; Shiri I; Zaidi H
Clin Oncol (R Coll Radiol); 2023 Nov; 35(11):713-725. PubMed ID: 37599160
[TBL] [Abstract][Full Text] [Related]
22. Prediction of MGMT Status for Glioblastoma Patients Using Radiomics Feature Extraction From
Qian J; Herman MG; Brinkmann DH; Laack NN; Kemp BJ; Hunt CH; Lowe V; Pafundi DH
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1339-1346. PubMed ID: 32634544
[TBL] [Abstract][Full Text] [Related]
23. Radiomics Analysis of PET and CT Components of
Wang X; Lu Z
Front Oncol; 2021; 11():638124. PubMed ID: 33928029
[TBL] [Abstract][Full Text] [Related]
24. Amide Proton Transfer Imaging in Predicting Isocitrate Dehydrogenase 1 Mutation Status of Grade II/III Gliomas Based on Support Vector Machine.
Han Y; Wang W; Yang Y; Sun YZ; Xiao G; Tian Q; Zhang J; Cui GB; Yan LF
Front Neurosci; 2020; 14():144. PubMed ID: 32153362
[TBL] [Abstract][Full Text] [Related]
25. Overall Survival Prognostic Modelling of Non-small Cell Lung Cancer Patients Using Positron Emission Tomography/Computed Tomography Harmonised Radiomics Features: The Quest for the Optimal Machine Learning Algorithm.
Amini M; Hajianfar G; Hadadi Avval A; Nazari M; Deevband MR; Oveisi M; Shiri I; Zaidi H
Clin Oncol (R Coll Radiol); 2022 Feb; 34(2):114-127. PubMed ID: 34872823
[TBL] [Abstract][Full Text] [Related]
26. Radiomics strategy for glioma grading using texture features from multiparametric MRI.
Tian Q; Yan LF; Zhang X; Zhang X; Hu YC; Han Y; Liu ZC; Nan HY; Sun Q; Sun YZ; Yang Y; Yu Y; Zhang J; Hu B; Xiao G; Chen P; Tian S; Xu J; Wang W; Cui GB
J Magn Reson Imaging; 2018 Dec; 48(6):1518-1528. PubMed ID: 29573085
[TBL] [Abstract][Full Text] [Related]
27. Machine learning-based CT radiomics approach for predicting WHO/ISUP nuclear grade of clear cell renal cell carcinoma: an exploratory and comparative study.
Xv Y; Lv F; Guo H; Zhou X; Tan H; Xiao M; Zheng Y
Insights Imaging; 2021 Nov; 12(1):170. PubMed ID: 34800179
[TBL] [Abstract][Full Text] [Related]
28.
Xu X; Sun X; Ma L; Zhang H; Ji W; Xia X; Lan X
Front Oncol; 2023; 13():1149791. PubMed ID: 36969043
[TBL] [Abstract][Full Text] [Related]
29. Radiomics signature based on FDG-PET predicts proliferative activity in primary glioma.
Kong Z; Li J; Liu Z; Liu Z; Zhao D; Cheng X; Li L; Lin Y; Wang Y; Tian J; Ma W
Clin Radiol; 2019 Oct; 74(10):815.e15-815.e23. PubMed ID: 31376917
[TBL] [Abstract][Full Text] [Related]
30. Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features.
Eertink JJ; Zwezerijnen GJC; Cysouw MCF; Wiegers SE; Pfaehler EAG; Lugtenburg PJ; van der Holt B; Hoekstra OS; de Vet HCW; Zijlstra JM; Boellaard R
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4642-4651. PubMed ID: 35925442
[TBL] [Abstract][Full Text] [Related]
31. Integrated CT Radiomics Features Could Enhance the Efficacy of
Zhou W; Huang Q; Wen J; Li M; Zhu Y; Liu Y; Dai Y; Guan Y; Zhou Z; Hua T
Front Oncol; 2021; 11():772703. PubMed ID: 34869011
[TBL] [Abstract][Full Text] [Related]
32. Glioma Survival Prediction with Combined Analysis of In Vivo
Papp L; Pötsch N; Grahovac M; Schmidbauer V; Woehrer A; Preusser M; Mitterhauser M; Kiesel B; Wadsak W; Beyer T; Hacker M; Traub-Weidinger T
J Nucl Med; 2018 Jun; 59(6):892-899. PubMed ID: 29175980
[TBL] [Abstract][Full Text] [Related]
33. An Optimal Radiomics Nomogram Based on
Feng L; Zhang S; Lu X; Yang X; Kan Y; Wang C; Zhang H; Wang W; Yang J
Acad Radiol; 2023 Oct; 30(10):2309-2320. PubMed ID: 37393177
[TBL] [Abstract][Full Text] [Related]
34. An investigation of machine learning methods in delta-radiomics feature analysis.
Chang Y; Lafata K; Sun W; Wang C; Chang Z; Kirkpatrick JP; Yin FF
PLoS One; 2019; 14(12):e0226348. PubMed ID: 31834910
[TBL] [Abstract][Full Text] [Related]
35. Exploring the association of glioma tumor residuals from incongruent [
Li X; Cheng Y; Han X; Cui B; Li J; Yang H; Xu G; Lin Q; Xiao X; Tang J; Lu J
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):779-796. PubMed ID: 37864593
[TBL] [Abstract][Full Text] [Related]
36. Contrast-enhanced computed tomography radiomics in predicting primary site response to neoadjuvant chemotherapy in high-risk neuroblastoma.
Wang H; Qin J; Chen X; Zhang T; Zhang L; Ding H; Pan Z; He L
Abdom Radiol (NY); 2023 Mar; 48(3):976-986. PubMed ID: 36571609
[TBL] [Abstract][Full Text] [Related]
37. Multimodality radiomics prediction of radiotherapy-induced the early proctitis and cystitis in rectal cancer patients: a machine learning study.
Abbaspour S; Barahman M; Abdollahi H; Arabalibeik H; Hajainfar G; Babaei M; Iraji H; Barzegartahamtan M; Ay MR; Mahdavi SR
Biomed Phys Eng Express; 2023 Dec; 10(1):. PubMed ID: 37995359
[No Abstract] [Full Text] [Related]
38. Association of CT-Based Delta Radiomics Biomarker With Progression-Free Survival in Patients With Colorectal Liver Metastases Undergo Chemotherapy.
Ye S; Han Y; Pan X; Niu K; Liao Y; Meng X
Front Oncol; 2022; 12():843991. PubMed ID: 35692757
[TBL] [Abstract][Full Text] [Related]
39. Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.
Kim M; Jung SY; Park JE; Jo Y; Park SY; Nam SJ; Kim JH; Kim HS
Eur Radiol; 2020 Apr; 30(4):2142-2151. PubMed ID: 31828414
[TBL] [Abstract][Full Text] [Related]
40. Radiomics assessment of bladder cancer grade using texture features from diffusion-weighted imaging.
Zhang X; Xu X; Tian Q; Li B; Wu Y; Yang Z; Liang Z; Liu Y; Cui G; Lu H
J Magn Reson Imaging; 2017 Nov; 46(5):1281-1288. PubMed ID: 28199039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
